DR. V. Reenaers
ActiveDR. V. Reenaers has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €304k and a net result of €15k. Equity is growing by ~6.7% per year across the filed fiscal years. Its solvency ranks better than 94% of 16426 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
94
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability75▼-1
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 28.32 against 23.78 in 2024; short-term debt: 3.2% and cash: 81.2% of total assets), and 3.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
96.8%
Return on assets
4.7%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
31 d early
2024
28 d early
2023
28 d early
2022
24 d early
2021
31 d early
2020
31 d early
2019
23 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€304k▲ 5.0%
2024 · €289k
2018: €183k
2019: €209k
2020: €220k
2021: €244k
2022: €260k
2023: €271k
2024: €289k
2018 → 2025
Total assets
€314k▲ 4.5%
2024 · €300k
2018: €205k
2019: €232k
2020: €239k
2021: €262k
2022: €268k
2023: €280k
2024: €300k
2018 → 2025
Net result
€15k▼ 16.8%
2024 · €18k
2018: €27k
2019: €28k
2020: €11k
2021: €23k
2022: €16k
2023: €12k
2024: €18k
2018 → 2025
Working capital
€278k▲ 7.6%
2024 · €259k
2018: €187k
2019: €218k
2020: €228k
2021: €251k
2022: €258k
2023: €271k
2024: €259k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€244k-€260k▲ 6.7%€271k▲ 4.5%€289k▲ 6.5%€304k▲ 5.0%
Operating result€33k-€23k▼ 29.4%€17k▼ 27.9%€25k▲ 48.2%€21k▼ 13.3%
Net result€23k-€16k▼ 30.3%€12k▼ 29.2%€18k▲ 51.5%€15k▼ 16.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €314k
Fixed assets
€25k▼ 16.7%
Current assets
€289k▲ 6.8%
Equity and liabilities €314k
Equity
€304k▲ 5.0%
Debt
€10k▼ 10.5%
The debt ratio falls from 3.8% to 3.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€29k▼
2024 · €30k
Cash flow
€23k▼
2024 · €23k
Solvency
96.8%▲
2024 · 96.2%
Current ratio
28.32▲
2024 · 23.78
Quick ratio
28.32▲
2024 · 23.78
Debt / equity
0.03▼
2024 · 0.04
ROE
4.8%▼
2024 · 6.1%
ROA
4.7%▼
2024 · 5.8%
Interest coverage
130.94▲
2024 · 128.73
Debt
€10k▼
2024 · €11k
Debt ≤ 1 year
€10k▼
2024 · €11k
Income taxes
€7k▼
2024 · €7k
Staff costs
€30k▲
2024 · €30k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€300k€314k▲
Fixed assets21/28€30k€25k▼
Tangible fixed assets22/27€30k€25k▼
Plant, machinery and equipment23€0€2k▲
Furniture and vehicles24€30k€23k▼
Other tangible fixed assets26€398€199▼
Current assets29/58€270k€289k▲
Amounts receivable within one year40/41€2k€2k▲
Other amounts receivable41€2k€2k▲
Cash at bank and in hand54/58€239k€255k▲
Deferred charges and accrued income490/1€29k€31k▲
Equity and liabilities
Total equity and liabilities10/49€300k€314k▲
Equity10/15€289k€304k▲
Contributions10/11€110k€110k=
Reserves13€179k€194k▲
Distributable reserves133€179k€194k▲
Amounts payable17/49€11k€10k▼
Amounts payable within one year42/48€11k€10k▼
Trade debts44€2k€2k▼
Suppliers440/4€2k€2k▼
Taxes, remuneration and social security45€9k€8k▼
Taxes450/3€2k€0▼
Remuneration and social security454/9€7k€8k▲
Other amounts payable47/48€301€0▼
Accrued charges and deferred income492/3€23€0▼
Income statement
Code20242025
Non-recurring operating income76A€10k€0▼
Remuneration, social security and pensions62€30k€30k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€8k▲
Other operating charges640/8€1k€878▼
Gross operating margin9900€61k€61k=
Operating profit (loss)9901€25k€21k▼
Financial income75/76B€0€8▲
Recurring financial income75€0€8▲
Financial charges65/66B€234€225▼
Recurring financial charges65€234€225▼
Profit (loss) for the period before taxes9903€24k€21k▼
Income taxes67/77€7k€7k▼
Profit (loss) for the period9904€18k€15k▼
Profit (loss) for the period to be appropriated9905€18k€15k▼
Appropriation of the result
Profit (loss) to be appropriated9906€18k€15k▼
Transfer to equity691/2€18k€15k▼
To other reserves6921€18k€15k▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
03-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
03-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €11k ▼58.6%
Net result drops to €11k, the lowest in the series; recovery starts the following year.
08-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Highest result since 2018net €28k ▲4.2%
Operating result €38k, net result €28k, both a record.
31-12
Financial
Equity above €200kEq €209k ▲13.7%
2 profitable years in a row build equity to €209k.
03-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
02-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
03-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2008
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Flinkstraat 343512 HasseltGround area
462 m²
Building footprint
101 m²
Volume, LiDAR
512 m³
Parcel 71055B0507/00T000, Flanders · tallest building 7.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. V. Reenaers
since 20082.171.980.448
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71055B0507/00T000 | Flanders | 462 m² | 1 · 101 m² | 7.0 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr JEAN-FRANCOIS JANSSENS
BE 0784.995.363
Ternat · Eq €304k
AMERA
BE 0805.007.255
Ieper · Eq €304k
DR. MC. DE JAEGER
BE 0898.591.964
Wingene · Eq €304k
Drs. Lintermans - van Riet
BE 0658.927.928
Antwerpen · Eq €303k
Docteur O. Joris Orthopédie
BE 0786.455.313
Anthisnes · Eq €304k
Of 16,621 companies in sector 86220 we hold annual accounts for 7,972. 6,654 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded27-05-2008
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.